Your browser is no longer supported. Please, upgrade your browser.
Settings
CTLT Catalent, Inc. daily Stock Chart
CTLT [NYSE]
Catalent, Inc.
Index- P/E46.30 EPS (ttm)0.96 Insider Own0.10% Shs Outstand145.06M Perf Week4.44%
Market Cap6.45B Forward P/E21.98 EPS next Y2.02 Insider Trans-22.17% Shs Float144.62M Perf Month9.86%
Income132.90M PEG3.56 EPS next Q0.46 Inst Own- Short Float2.38% Perf Quarter25.89%
Sales2.49B P/S2.59 EPS this Y9.40% Inst Trans-0.02% Short Ratio4.10 Perf Half Y7.45%
Book/sh10.77 P/B4.13 EPS next Y10.07% ROA3.00% Target Price49.30 Perf Year5.38%
Cash/sh- P/C- EPS next 5Y13.00% ROE10.40% 52W Range29.23 - 46.43 Perf YTD42.56%
Dividend- P/FCF59.65 EPS past 5Y27.70% ROI6.10% 52W High-4.39% Beta1.69
Dividend %- Quick Ratio1.60 Sales past 5Y6.50% Gross Margin31.10% 52W Low51.86% ATR1.29
Employees10700 Current Ratio2.10 Sales Q/Q2.80% Oper. Margin10.60% RSI (14)63.33 Volatility2.65% 2.95%
OptionableYes Debt/Eq1.41 EPS Q/Q84.40% Profit Margin5.50% Rel Volume0.28 Prev Close44.45
ShortableYes LT Debt/Eq1.36 EarningsMay 07 BMO Payout0.00% Avg Volume840.12K Price44.39
Recom1.90 SMA207.29% SMA505.78% SMA20010.80% Volume149,234 Change-0.13%
Apr-16-19Upgrade UBS Neutral → Buy $43 → $54
Nov-07-18Upgrade First Analysis Sec Neutral → Outperform $47 → $43
Oct-09-18Initiated UBS Neutral
Mar-28-18Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Mar-21-18Upgrade Raymond James Mkt Perform → Outperform
Feb-06-18Downgrade Stephens Overweight → Equal-Weight
Sep-21-17Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-13-17Initiated Needham Hold
Sep-08-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Dec-01-16Initiated Goldman Neutral
Oct-20-16Initiated KeyBanc Capital Mkts Overweight $29
Jun-21-16Upgrade Wells Fargo Market Perform → Outperform
Jun-20-16Upgrade BofA/Merrill Neutral → Buy
May-05-16Downgrade BofA/Merrill Buy → Neutral
Apr-21-16Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-10-16Reiterated Deutsche Bank Hold $31 → $24
Dec-22-15Downgrade Wells Fargo Outperform → Market Perform
Dec-09-15Downgrade Raymond James Outperform → Mkt Perform
Nov-04-15Reiterated Deutsche Bank Hold $33 → $31
Sep-10-15Downgrade Jefferies Buy → Hold $32 → $29
Apr-24-19 10:52AM  Did Hedge Funds Drop The Ball On Catalent Inc (CTLT) ? Insider Monkey
Apr-17-19 04:05PM  Catalent Pharma Solutions, Inc. -- Moody's announces completion of a periodic review of ratings of Catalent Pharma Solutions, Inc. Moody's
11:37AM  Catalent Pharma Solutions, Inc. -- Moody's: Catalent's acquisition of Paragon will increase leverage, a credit negative Moody's
Apr-15-19 03:33PM  Catalent seeks slice of gene therapy market with Paragon buy Reuters +13.12%
09:53AM  Catalent to Buy Paragon Bioservices for $1.2 Billion TheStreet.com
09:27AM  Catalent Agrees To Buy Gene Therapy-Focused CDMO Paragon Services For $1.2B Benzinga
08:12AM  Stocks making the biggest moves premarket: Goldman Sachs, CVS, Best Buy, Facebook & more CNBC
07:38AM  Catalent pushes into gene therapy with $1.2 bln buyout of Paragon Bioservices Reuters
07:15AM  Catalent to acquire Paragon Bioservices for $1.2 billion in cash MarketWatch
07:13AM  Catalent to buy Paragon Bioservices for $1.2 bln Reuters
07:02AM  Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion PR Newswire
07:00AM  Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion Business Wire
Apr-14-19 11:17PM  Catalent to buy Paragon Bioservices for $1.2 billion - WSJ Reuters
07:42PM  Catalent to buy Paragon Bioservices for $1.2 bln - WSJ Reuters
07:39PM  Catalent to buy Paragon Bioservices for $1.2 bln -WSJ Reuters
06:08PM  Catalent to buy Paragon Bioservices for $1.2 bln -WSJ Reuters
Apr-11-19 07:13AM  Update: Catalent (NYSE:CTLT) Stock Gained 34% In The Last Three Years Simply Wall St.
Apr-09-19 04:15PM  Catalent, Inc. Announces Third Quarter Fiscal Year 2019 Earnings Conference Webcast Business Wire
Apr-03-19 09:30AM  CTLT or ORINY: Which Is the Better Value Stock Right Now? Zacks
07:30AM  Biohaven Broadens Senior Leadership Team With Veteran Pharma Commercial Experience PR Newswire
Mar-15-19 09:30AM  CTLT or NBIX: Which Is the Better Value Stock Right Now? Zacks
Mar-07-19 06:07AM  Is Catalent, Inc.s (NYSE:CTLT) Balance Sheet A Threat To Its Future? Simply Wall St.
Mar-06-19 04:15PM  Catalent, Inc. to Present at the Barclays Global Healthcare Conference Business Wire
Mar-04-19 11:40PM  Champions Oncology (CSBR) Q3 Earnings: What's in Store? Zacks
Feb-27-19 09:57AM  The Zacks Analyst Blog Highlights: Celgene, Charles River Laboratories International, Catalent and Aeterna Zentaris Zacks
Feb-26-19 08:55AM  4 Drug Stocks to Buy Despite Price Hearing Woes Zacks
Feb-15-19 08:16AM  Will Catalent Continue to Surge Higher? Zacks
Feb-13-19 07:00AM  Catalent Names Alessandro Maselli President and Chief Operating Officer Business Wire
Feb-12-19 09:30AM  CTLT vs. NBIX: Which Stock Should Value Investors Buy Now? Zacks
Feb-07-19 09:35PM  Edited Transcript of CTLT earnings conference call or presentation 5-Feb-19 1:15pm GMT Thomson Reuters StreetEvents
Feb-05-19 12:55PM  Catalent Inc (CTLT) Q2 2019 Earnings Conference Call Transcript Motley Fool +5.06%
08:55AM  Catalent (CTLT) Beats Q2 Earnings and Revenue Estimates Zacks
07:52AM  Catalent: Fiscal 2Q Earnings Snapshot Associated Press
07:30AM  Catalent, Inc. Reports Second Quarter Fiscal 2019 Results Business Wire
Jan-29-19 10:31AM  Analysts Estimate Catalent (CTLT) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-28-19 07:55AM  Investor Expectations to Drive Momentum within Cognizant Technology Solutions, Public Service Enterprise Group, Iron Mountain, Catalent, QuinStreet, and Entravision Communications Discovering Underlying Factors of Influence GlobeNewswire
Jan-26-19 08:12AM  A Closer Look At Catalent, Inc.s (NYSE:CTLT) Uninspiring ROE Simply Wall St.
Jan-14-19 04:15PM  Catalent, Inc. Announces Second Quarter Fiscal Year 2019 Earnings Conference Webcast Business Wire
Jan-08-19 02:52PM  Catalent to expand Wisconsin biomanufacturing operation Associated Press
12:58PM  Catalent to expand Wisconsin biomanufacturing operation Associated Press
Jan-07-19 07:00AM  Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities Business Wire
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals
Dec-19-18 04:15PM  Catalent, Inc. to Present at the 37th Annual J.P. Morgan Health Care Conference Business Wire
Dec-12-18 12:20AM  Is Catalent Inc (CTLT) A Good Stock To Buy? Insider Monkey
Dec-10-18 09:29AM  Moving Average Crossover Alert: Catalent Zacks
Dec-03-18 03:00AM  Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine PR Newswire
Nov-28-18 09:15AM  Stocks Hold Onto Gains Ahead of Powell Speech Zacks
Nov-19-18 05:53PM  Edited Transcript of CTLT earnings conference call or presentation 6-Nov-18 1:15pm GMT Thomson Reuters StreetEvents
Nov-07-18 07:21AM  What Does Catalent Incs (NYSE:CTLT) P/E Ratio Tell You? Simply Wall St.
Nov-06-18 11:47AM  Catalent Inc (CTLT) Q1 2019 Earnings Conference Call Transcript Motley Fool -12.86%
07:48AM  Catalent: Fiscal 1Q Earnings Snapshot Associated Press
07:30AM  Catalent, Inc. Reports First Quarter Fiscal 2019 Results Business Wire
06:37AM  Is Catalent Incs (NYSE:CTLT) CEO Incentives Align With Yours? Simply Wall St.
Oct-31-18 04:15PM  Catalent, Inc. to Present at Three Upcoming Investor Conferences Business Wire
Oct-23-18 07:45AM  Report: Exploring Fundamental Drivers Behind The Home Depot, uniQure N.V, Catalent, Apple, BioTime, and PDL BioPharma New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-08-18 04:15PM  Catalent, Inc. Announces First Quarter Fiscal Year 2019 Earnings Conference Webcast Business Wire
Oct-03-18 08:15PM  Catalent Inc (CTLT) Chair, President & CEO John R Chiminski Sold $5.9 million of Shares GuruFocus.com
Sep-21-18 10:53AM  Edited Transcript of CTLT earnings conference call or presentation 28-Aug-18 12:15pm GMT Thomson Reuters StreetEvents
Sep-19-18 07:12AM  New Strong Sell Stocks for September 19th Zacks
Aug-28-18 08:50AM  Catalent (CTLT) Q4 Earnings Top Estimates Zacks
07:51AM  Catalent: Fiscal 4Q Earnings Snapshot Associated Press
07:50AM  Research Report Identifies Scientific Games, Accuray, Shake Shack, MoneyGram International, G-III Apparel Group, LTD, and Catalent with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
07:30AM  Catalent, Inc. Reports Fourth Quarter Fiscal 2018 Results Business Wire
Aug-14-18 03:00AM  Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc. Business Wire
Aug-06-18 10:44AM  Catalent Pharma Solutions, Inc. -- Moody's upgrades Catalent's senior secured ratings to Ba2 Moody's
Jul-30-18 11:42AM  Why the Earnings Surprise Streak Could Continue for Catalent (CTLT) Zacks
Jul-26-18 08:42AM  Catalent (CTLT) Catches Eye: Stock Jumps 5.2% Zacks
Jul-24-18 06:34PM  Catalent, Inc. Announces Pricing of Public Offering of Common Stock Business Wire -8.30%
04:41PM  Catalent Pharma Solutions, Inc. -- Moody's: Catalent's plan to use equity offering proceeds for debt repayment is credit positive Moody's
Jul-23-18 04:05PM  Catalent, Inc. Announces Public Offering of Common Stock Business Wire
Jul-19-18 04:15PM  Catalent, Inc. Announces Fourth Quarter Fiscal Year 2018 Earnings Conference Webcast Business Wire
Jul-17-18 09:30AM  CTLT vs. ZTS: Which Stock Is the Better Value Option? Zacks
Jul-16-18 02:13PM  MERGER ALERT CVG, JNP, and WEB: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies GlobeNewswire
Jul-11-18 12:00PM  MERGER ALERT -- WEB, EDR, JNP: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies GlobeNewswire
Jul-10-18 01:03PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation of Juniper Pharmaceuticals, Inc. - JNP PR Newswire
Jul-08-18 11:28AM  CORRECTING and REPLACING Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc. Business Wire
Jul-06-18 03:16PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Juniper Pharmaceuticals, Inc. to Catalent Inc. is Fair to Shareholders GlobeNewswire
07:10AM  Wired News - Catalent Acquires Juniper Pharma ACCESSWIRE
Jul-05-18 04:33PM  WeissLaw LLP Investigates Juniper Pharmaceuticals, Inc. PR Newswire
09:40AM  Company News For Jul 5, 2018 Zacks
Jul-04-18 08:28AM  Juniper Inks Deal to be Acquired by Catalent, Shares Up Zacks
Jul-03-18 11:07AM  Catalent to acquire Boston's Juniper Pharmaceuticals for $128M American City Business Journals
04:51AM  Catalent to buy Juniper Pharmaceuticals for $11.50 per share Reuters
03:00AM  Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc. Business Wire
Jun-28-18 07:50AM  Free Research Reports on Catalent and Three More Generic Drugs Stocks ACCESSWIRE
Jun-27-18 10:39AM  Achieve Life Sciences' Shares Rise on Positive Clinical Data Zacks
Jun-26-18 08:30AM  Investor Expectations to Drive Momentum within AMC Entertainment, Arrowhead Pharmaceuticals, U.S. Silica, Catalent, RSP Permian, and KapStone Paper and Packaging Discovering Underlying Factors of Influence GlobeNewswire
Jun-23-18 09:47AM  Did Catalent Inc (NYSE:CTLT) Create Value For Investors Over The Past Year? Simply Wall St.
Jun-22-18 09:56AM  Shire (SHPG) HAE Drug Gets FDA Nod for Pediatric Population Zacks
Jun-20-18 09:30AM  CTLT vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
May-22-18 03:39PM  Tenant on former Marion Labs campus completes $5.5M expansion American City Business Journals
May-15-18 04:15PM  Biohaven Pharmaceuticals Reports First Quarter 2018 Financial and Recent Business Results PR Newswire
May-14-18 07:30AM  Wired News Zomedica Inks Deal with Seraph to Develop and Market Seraphs Novel Pathogen Detection System for Veterinarians ACCESSWIRE
May-09-18 04:15PM  Catalent, Inc. to Present at Four Upcoming Investor Conferences Business Wire
07:35AM  Consolidated Research: 2018 Summary Expectations for Catalent, MGIC Investment, United Rentals, Clovis Oncology, Pure Storage, and Chipotle Mexican Grill Fundamental Analysis, Key Performance Indications GlobeNewswire
May-03-18 04:03AM  Edited Transcript of CTLT earnings conference call or presentation 1-May-18 12:15pm GMT Thomson Reuters StreetEvents
May-01-18 09:05AM  Catalent: Fiscal 3Q Earnings Snapshot Associated Press
07:45AM  Catalent, Inc. Reports Third Quarter Fiscal 2018 Results Business Wire
Apr-30-18 02:48PM  Catalent Q3 Earnings Outlook Benzinga
Apr-27-18 08:46AM  Should You Sell Catalent (CTLT) Before Earnings? Zacks
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. The Softgel Technologies segment formulates, develops, and manufactures prescription and consumer soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics and Specialty Drug Delivery segment formulates, develops, and manufactures small molecule and biologic drug products in prefilled syringes, vials and cartridges, blow-fill-seal unit doses, and injectable formats; develops biologic cell lines; manufactures biologic drug substances; and offers bioanalytical development and testing services. The Oral Drug Delivery segment formulates, develops, and manufactures oral dosage forms using proprietary and conventional drug delivery technologies, such as Zydis, OptiDose CR, OptiPact, OptiForm API and Solution Suite, Pharmatek SD Spray Drying, OptiMelt hot melt extrusion, Micron particle size reduction, and FlexDose; and provides stick pack formulation and filling, and analytical development and testing services. The Clinical Supply Services segment offers Manufacturing, packaging, labeling, storage, distribution, and inventory management for drugs and biologics clinical trials; FastChain demand-led clinical supply services; clinical e-solutions and informatics; and comparator sourcing services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gennadios AristipposPresident, Softgel Tech.Mar 21Option Exercise10.7113,528144,88544,862Mar 25 05:50 PM
Gennadios AristipposPresident, Softgel Tech.Mar 21Sale42.183,392143,08934,726Mar 25 05:50 PM
Miyamoto LanceSVP, Human ResourcesMar 07Option Exercise15.34123,6101,896,337130,793Mar 11 07:31 PM
Miyamoto LanceSVP, Human ResourcesMar 07Sale42.4943,6191,853,37846,799Mar 11 07:31 PM
Downie WilliamSVP, Global Sales & MarketingFeb 15Option Exercise24.6912,457307,50545,231Feb 20 03:48 PM
Downie WilliamSVP, Global Sales & MarketingFeb 15Sale42.007,315307,23034,926Feb 20 03:48 PM
GREISCH JOHN JDirectorNov 08Buy37.6113,000488,93013,000Nov 13 08:28 AM
Miyamoto LanceSVP, Human ResourcesOct 16Option Exercise12.1418,000218,52064,799Oct 18 11:59 AM
Miyamoto LanceSVP, Human ResourcesOct 16Sale42.506,525277,31346,799Oct 18 11:59 AM
Littlejohns BarryPresident, Biologics & SDDOct 15Option Exercise14.86144,8112,151,891125,218Oct 17 12:28 PM
Littlejohns BarryPresident, Biologics & SDDOct 15Sale41.6447,2651,968,11537,718Oct 17 12:28 PM
Chiminski John RChair, President & CEOOct 01Option Exercise21.05286,3586,027,735416,074Oct 03 05:53 PM
Chiminski John RChair, President & CEOOct 01Sale45.32130,5455,916,299229,690Oct 03 05:53 PM
MOREL DONALD E JRDirectorSep 13Buy43.0010,000430,00036,958Sep 17 10:56 AM
Fasman Steven LSVP & General CounselJun 20Option Exercise24.2615,458375,01156,522Jun 21 12:46 PM
Fasman Steven LSVP & General CounselJun 20Sale41.782,25294,08943,316Jun 21 12:46 PM